NCT07930832
Study to Compare Traditional and Emerging Methods for Structural Variant Analysis in Prenatal, Postnatal, and Hematologic Samples
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Overall diagnostic concordance between KaryoSolver and reference methods for the identification of clinically detectable structural variants.
Timeframe: through study completion, an average of 1 year
Agreement on the presence/absence of clinically relevant chromosomal alterations between KaryoSolver and reference methods
Timeframe: through study completion, an average of 1 year
Agreement by category of identified alteration (aneuploidies, deletions, duplications) between KaryoSolver and reference methods
Timeframe: through study completion, an average of 1 year
Percentage of cases correctly classified by KaryoSolver compared to the reference comparator
Timeframe: through study completion, an average of 1 year
Secondary (7)
Intra-run reproducibility of KaryoSolver, assessed as the agreement of results obtained from replicates analyzed in the same session
Inter-run reproducibility of KaryoSolver, assessed as the agreement of results obtained from replicates analyzed in different sessions
Average analytical run time per sample with KaryoSolver compared to reference methods
Average total reporting time/turnaround time with KaryoSolver compared to reference methods.
Reduction in technical/interpretive workload, assessed in terms of man-hours or the number of manual tasks required
Show 2 moreShow less
Average cost per sample analyzed with KaryoSolver compared to reference methods
Proportion of cases potentially eligible for faster diagnosis using KaryoSolver compared to the standard workflow
Sites
2 sites in 1 country